Morning Market Losers
September 05, 2014 at 09:43 AM EDT
Recro Pharma (NASDAQ: REPH) dipped 46.41% to $3.06 after the company reported that its trial study is not seen reaching statistical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.